Net income took a step backward in the second quarter, as the for-profit hospital conglomerate struggled with expense control.
Shares slump after the company's second-quarter results come up short.
Shares slide after the company reported second-quarter results that missed the mark.
The regional bank continues to crank out steady results and has authorized a new $100 million stock repurchase plan.
Which retail drugstore chain is more worthy of your investment dollars?
Shares are heading in opposite directions after the two cancer diagnostic companies surprised Wall Street by revealing plans to merge. Here's what investors need to know.
These businesses might be small, but the potential returns could be huge.
Revenue and gross margin continue to be strong, but acquisition costs continue to put pressure on the bottom line.
Shares fall after the company reports second-quarter results that missed the mark.
These three businesses are poised to profit from the war on cancer.
Shares slump after the radiation-therapy company reported mixed quarterly results.
Shares jump after the company reports strong quarterly results and management shares some news about Medicare.
The innovative oncology company posted 41% revenue growth and achieved positive operating income for the first time in its history.
Everything is going well for the life sciences service provider.
Shares slumped after the company reported results that missed the mark.
Sales and profits took a step backward in the second quarter as the company continues to deal with customer issues.
Find out which stocks have our team of healthcare experts feeling excited right now.
Shares jump after the biopharma receives some praise from Wall Street.
Shares slump after the drugmaker releases bummer clinical news.
Autodesk is the $30 billion SaaS company that hardly anyone has heard of, and it’s set up for serious growth.